MedicaidCoverageLow impact
Newsletter Vol. 17, No. 09
New Jersey Medicaid·NJ·Pharmacy
Effective date
Apr 20, 2007
We identified it
Jun 20, 2026
Summary
Two pharmaceutical manufacturers (RESPA Pharmaceuticals and Gilead Sciences) have been added to the New Jersey PAAD Drug Rebate Program, expanding coverage for legend drugs, diabetic testing supplies, and insulin for eligible aged and disabled patients.
Action Required
No immediate action required for billing teams. This is an informational update about manufacturer participation in New Jersey's PAAD program that affects drug coverage eligibility but does not change billing procedures or codes.